284 related articles for article (PubMed ID: 11531318)
21. Emergency department waiting times for patients with cancer with febrile neutropenia: a pilot study.
Nirenberg A; Mulhearn L; Lin S; Larson E
Oncol Nurs Forum; 2004 Jul; 31(4):711-5. PubMed ID: 15252427
[TBL] [Abstract][Full Text] [Related]
22. [Empirical antibiotic therapy in febrile neutropenic patients with acute leukemia].
Yabe H; Nakamura F; Ishikawa T; Nagai K; Nakayama S
Rinsho Ketsueki; 1989 May; 30(5):644-9. PubMed ID: 2795878
[TBL] [Abstract][Full Text] [Related]
23. Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation.
Egerer G; Goldschmidt H; Hensel M; Harter C; Schneeweiss A; Ehrhard I; Bastert G; Ho AD
Bone Marrow Transplant; 2002 Oct; 30(7):427-31. PubMed ID: 12368954
[TBL] [Abstract][Full Text] [Related]
24. Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes.
Zuckermann J; Moreira LB; Stoll P; Moreira LM; Kuchenbecker RS; Polanczyk CA
Ann Hematol; 2008 Feb; 87(2):139-45. PubMed ID: 17938926
[TBL] [Abstract][Full Text] [Related]
25. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
26. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
27. Empirical antifungal therapy in selected patients with persistent febrile neutropenia.
Aguilar-Guisado M; Espigado I; Cordero E; Noguer M; Parody R; Pachón J; Cisneros JM
Bone Marrow Transplant; 2010 Jan; 45(1):159-64. PubMed ID: 19525983
[TBL] [Abstract][Full Text] [Related]
28. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
29. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
30. [Aztreonam and oxacillin in the treatment of febrile neutropenic patients with solid tumors].
Natali M; Tonini G; Tufo E; Leggio M; Carassai A; Lopez M
Clin Ter; 1989 Sep; 130(5):239-44. PubMed ID: 2530024
[TBL] [Abstract][Full Text] [Related]
31. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
[TBL] [Abstract][Full Text] [Related]
32. Prophylaxis and treatment of bacterial infections: do we need new strategies?
Micozzi A; Bucaneve G
Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
[TBL] [Abstract][Full Text] [Related]
33. Febrile neutropenia in haematological malignancies.
Sharma A; Lokeshwar N
J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
[TBL] [Abstract][Full Text] [Related]
34. How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?
Raad II; Abi-Said D; Rolston KV; Karl CL; Bodey GP
Cancer; 1998 Jun; 82(12):2449-58. PubMed ID: 9635539
[TBL] [Abstract][Full Text] [Related]
35. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
Girmenia C; Russo E; Carmosino I; Breccia M; Dragoni F; Latagliata R; Mecarocci S; Morano SG; Stefanizzi C; Alimena G
Ann Hematol; 2007 Apr; 86(4):263-70. PubMed ID: 17225113
[TBL] [Abstract][Full Text] [Related]
36. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
[TBL] [Abstract][Full Text] [Related]
37. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
38. [Management of 315neutropenic febrile episodes in a cancer center].
Dutronc H; Billhot M; Dupon M; Eghbali H; Donamaria C; Dauchy FA; Reiffers J
Med Mal Infect; 2009 Jun; 39(6):388-93. PubMed ID: 19062208
[TBL] [Abstract][Full Text] [Related]
39. Piperacillin-tazobactam monotherapy in high-risk febrile and neutropenic cancer patients.
Viscoli C; Cometta A; Kern WV; Bock R; Paesmans M; Crokaert F; Glauser MP; Calandra T;
Clin Microbiol Infect; 2006 Mar; 12(3):212-6. PubMed ID: 16451406
[TBL] [Abstract][Full Text] [Related]
40. Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient.
De Pauw BE; Raemaekers JM; Schattenberg T; Donnelly JP
J Intern Med Suppl; 1997; 740():69-77. PubMed ID: 9350186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
